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Abstract
As the complexity of cellular signaling in inflammatory response
emerges, it is increasingly clear that mitochondria are directly
involved in, and in some cases are even required for, activation
of inflammatory response. As a bioenergetic organellar network,
mitochondria dynamically modulate their organization and
function in response to cellular signaling cues and metabolic
demand. The NLRP3 inflammasome, a caspase-activating
multifactor scaffolding assembly, is directly activated by
mitochondrial factors and functional parameters. Mitochondria are
also heavily implicated as downstream targets of inflammation in
a variety of tissues. Elevated inflammation and cytokine-mediated
damage to mitochondria are implicated in the pathogenesis of
disparate conditions such as Type 2 diabetes and autism spectrum
disorders. Recent findings indicate that mitochondrial factors are
released as extracellular mediators of inflammatory response.
Here, we discuss the mechanistic interaction of mitochondria in
inflammatory signaling, as well as the implications for inflammatory
mitochondrial damage as a causative force in highly prevalent
human diseases.

binding of extracellular ligands, these PRRs activate intracellular
signaling events, such as activation of NFκB, a transcription factor
that upregulates expression of a wide variety of stress-response genes,
or through post-translational modification such as activation of c-Jun
amino-terminal kinase (JNK) [2] to effect inflammatory response.
Within the cytoplasm, inflammatory ligands bind and activate
intracellular PRRs that combine with a variety of associated factors
to form large cytoplasmic scaffolding assemblies that integrate
inflammatory activation and activate secretion of the major
cytokines IL-1β and IL-18 by binding and activating caspase-1 [3]
(Figure 1). These cytoplasmic PRRs, classed as nucleotide-binding
domain leucine-rich repeat-containing receptors (NLRs), recognize
a wide variety of intracellular inflammatory stimuli. Four classes
of NLRs (NLRP1, NLRP3, NLRC4 and AIM2) share in common a
nucleotide-binding oligomerization domain, and have demonstrated
an ability to form large oligomeric inflammasome complexes in the
cytoplasm [4]. While each of the four sense a variety of inflammatory
signals to mediate caspase-dependent activation of inflammation, the
NLRP3 inflammasome is the best characterized.

Inflammatory Signaling and Innate Immune Response
Inflammation is a crucial mechanism of innate immune response.
Macrophages and neutrophils recognize pathogen-associated
molecular patterns (PAMPs) and damage-associated molecular
patterns (DAMPs), undergoing a complex set of signaling
interactions to release pro-inflammatory cytokines (most notably
IL-1β and IL-18 [1] that prompt inflammatory response. To
mediate innate immune response, pattern-recognition receptors
(PRRs) recognize a broad range of markers of infection, stress, and
damage. PRRs include membrane-bound receptors such as Toll-like
receptors (TLRs), the interleukin receptors (ILRs), and the tumor
necrosis factor receptors 1 (TNF-R1) and 2 (TNF-R2). Upon
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Figure 1: Schematic of mitochondrial interactions with NLRP3 inflammasome
signaling.

Plasma membrane PRRs TLR, ILR, and TNF-R (red boxes) bind
cytokines and extracellular ligands, activating NFκB and JNK, which
activate nuclear transcription of cellular stress factors, particularly
NLRP3. NLRP3 (blue), ASC (gold), and caspase-1 (purple) associate
in the cytoplasm as the large, macromolecular NLRP3 inflammasome
in macrophages. Mitochondria are impacted by membrane-bound
PRR signals and aid in activating the NLRP3 inflammasome (via

Citation: Gilkerson R, Materon L (2014) Two Roads Converging: Mitochondria and Inflammatory Signaling. J Clin Immunol Immunother 1: 004.

• Page 2 of 7 •

ROS or specific interaction with mtDNA, cardiolipin, MFN2, or
MAVS). Inflammasome activation results in cleavage of pro-IL-1β and
pro-IL-18 to active cytokines IL-1β and IL-18, which are secreted
from the cell to spread inflammation.

The NLRP3 Inflammasome
The NACHT, LRR, and PYD domain-containing protein (NLRP3)
is a major mediator of caspase-1 activation. To accomplish this, NLRP3
associates with the apoptosis-associated speck-like protein containing
a CARD domain (ASC) adaptor protein. ASC contains a caspase
recruitment domain (CARD), thus allowing binding of pro-caspase-1
to the inflammasome complex. ASC has a remarkable ability to
dimerize and associate with pro-caspase-1, causing formation of a
single large (~2 μm diameter) NLRP3 inflammasome in macrophages
[5].
Formation of the NLRP3 inflammasome is cued by the
membrane-bound PRRs, such as the TLRs, ILRs, and TNF-Rs,
which activate NFκB and JNK in the nucleus NFκB is a major
stress-response transcription factor, which rapidly increases mRNA
levels of pro-inflammatory factors, particular NLRP3 and pro-IL-1β
[6,7]. For inflammasome formation, NFκB-mediated increases in
transcription of both NLRP3 and pro-IL-1β are required, as
these factors are found at low basal levels. Conversely, ASC and
pro-caspase-1 (as well as pro-IL-18) are found at sufficiently high
levels in the cytoplasm to allow inflammasome assembly [6]. Upon
binding of caspase-1 as part of the NLRP3 inflammasome, the
inactive pro-caspase-1 is autocatalytically cleaved and forms the active
caspase-1 heterodimer [8,9]. Active caspase-1 then cleaves proIL-1β
and pro-IL-18 to their active Il-1β and IL-18 forms, which are then
secreted as inflammatory cytokines [8-10] (Figure 1). An exciting
collection of findings indicates that a variety of factors located in the
mitochondria play a crucial role in NLRP3 inflammasome response.

Mitochondria: A Dynamic Organellar Network

supplied by NADH and FADH2, ultimately donated to molecular
oxygen to create water, to drive H+ pumping from the mitochondrial
matrix to the intermembrane space. This H+ pumping activity
generates a proton-motive force, which in higher organisms is
chiefly comprised of an electrochemical gradient, or transmembrane
potential (∆ψm) that is then utilized by the F1F0 ATP synthase [16]. By
allowing a single H+ to return to the matrix down the gradient, ADP
and Pi are bound at the F1 portion of the ATP synthase and coalesced
to ATP during the rotation-mediated conformational shifting of the
holoenzyme [17].
Mitochondrial structure is organized to support bioenergetic
function. While traditional models of mitochondrial ultrastructure
envisioned a collection of individual organelles dispersed throughout
the cytoplasm, advances in cellular imaging and the identification of
genetic factors controlling mitochondrial morphology have combined
to reveal mitochondrial ultrastructure as a highly dynamic, sensitive
process capable of dramatic response to cellular stimuli. Mitochondria
were originally named as being ‘thread-like granules’. Improved
imaging techniques revealed that mitochondria do in fact have the
ability to interconnect as a networked reticulum throughout the cell
[12,18]. Optic atrophy 1 (OPA1) was identified as a factor that is
required for fusion of the mitochondrial inner membrane [19],
while mitofusin 1 (MFN1) and mitofusin 2 (MFN2) carry out fusion
of the outer mitochondrial membrane (Hoppins et al., 2007).
While OPA1, MFN1, and MFN2 carry out mitochondrial fusion, a
different set of factors carry out mitochondria fission. FIS1 [20] and
MFF [21] are mitochondrial outer membrane proteins that recruit
dynamin-related protein 1 (DRP1) from the cytoplasm. Upon
docking at the outer membrane, DRP1 will form multimeric rings
around a mitochondrion, dividing it in two [23]. Thus, mitochondrial
fusion and fission are opposing processes governed by different sets
of factors, in which a cell will balance mitochondrial organization
between the two (Figure 2).

As organelles of endosymbiontic origin [11], mitochondria
occupy a highly unique niche in cellular biology. By combining
genetic contributions from both chromosomal and mitochondrial
genomes, mitochondria carry out the bulk of cellular ATP production
via oxidative phosphorylation. Mitochondrial structure is incredibly
dynamic, changing in response to cellular need and organellar
bioenergetic function, even in cells with highly constrained
architecture such as cardiac [12] and skeletal muscle fibers [13]. This
dynamic structure undergoes profound alteration in response to
mitochondrial dysfunction, indicating that structural dynamics
represent a critical parameter to be explored in mitochondrial-immune interactions.
The dual genetic composition of mitochondria is unique among
the organelles of a human cell: both nuclear- and mitochondrially-encoded gene products are required
to fully assemble the five complexes of oxidative phosphorylation (OxPhos) in the mitochondrial
inner membrane. While hundreds of proteins are present in human
mitochondria [14,15], the vast majority of these are encoded by
nuclear genes. Mitochondrial DNA (mtDNA) encodes only 2 rRNAs,
22 tRNAs, and 13 polypeptides from a 16,569 bp circular DNA.
Despite the small handful of proteins encoded by mtDNA, these
polypeptides are essential subunits of the OxPhos complexes in the
inner membrane. While Complex II is encoded solely by nuclear
DNA, the other four complexes each contain at least one
mtDNA-encoded polypeptide. Complexes I-IV transfer electrons
J Clin Immunol Immunother ISSN: 2378-8844, Open Access Journal
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Figure 2: 3T3 mouse embryonic fibroblasts visualized by confocal
fluorescence microscopy, labeled for mitochondria (MitoTracker, red) and the
nucleus (DAPI, blue).
Volume 1 • Issue 1 • 100004

Citation: Gilkerson R, Materon L (2014) Two Roads Converging: Mitochondria and Inflammatory Signaling. J Clin Immunol Immunother 1: 004.

• Page 3 of 7 •

The cell’s mitochondria display both interconnected, fused
mitochondria (to the right of the nucleus) and fragmented, divided
mitochondria (to the left of the nucleus). Size bar = 10 μm.
Mitochondrial ultrastructure is directly tied to mitochondrial
function, existing in a sensitive balance to maintain energetic
homeostasis. Damage or dysfunction to the structure/function
balance of mitochondria causes a loss of ability to maintain a fused,
interconnected mitochondrial network. Cells with either genetic [23]
or pharmacologically-induced mitochondrial dysfunction [24] have
mitochondria that are unable to fuse together, instead maintaining
an obligately fragmented organization. This loss of organellar fusion
under conditions of mitochondrial dysfunction is caused by
proteolytic cleavage of the OPA1 fusion protein [25], occuring when
the ∆ψm across the mitochondrial inner membrane is low [26].
Subsequently, ∆ψm-sensitive cleavage of OPA1 was found to be
mediated by OMA1, a metalloprotease located in the inner
mitochondrial membrane [27,28]. Thus, mitochondrial function
(specifically ∆ψm) directly mediates mitochondrial fusion by OPA1,
while transgenic ablation of either mitochondrial fission [29] or fusion
[30] negatively impacts bioenergetic function, indicating the
hand-in-hand relationship between mitochondrial bioenergetic
function and structural organization. Moreover, while bioenergetic
dysfunction and loss of efficient mitochondrial organization are
detrimental in and of themselves, emerging evidence suggests
that mitochondrial dysfunction plays a strong role in activation of
NLRP3-mediated inflammatory signaling (discussed below). As
mitochondrial structural dynamics are directly linked to processes
including apoptosis and autophagy [31,32], mitochondrial-inflammatory interactions are likely to be similarly linked to a fascinating set
of dynamic alterations, with enormous consequences for the cell and
surrounding environment.

Mitochondria in NLRP3 Inflammasome Signaling
Mitochondria are emerging as a major activator of NLRP3
inflammasome signaling, and are in some cases required for NLRP3
inflammasome activation. Recent findings show that a variety of
mitochondrial components interacts with and activate the NLRP3
inflammasome as major contributors to innate immune signaling
by macrophages. Even more intriguingly, Misawa et al. showed that
mitochondria are recruited en masse to the inflammasome within
the cytoplasm of macrophages [33], suggesting that a host of other
mitochondrial factors may have critical roles in inflammasome-mediated signaling.
A role for mitochondria in NLRP3 inflammasome signaling was
first suggested when mitochondria were observed to colocalize with
the NLRP3/ASC/caspase-1 scaffold assembly upon inflammasome
induction. While reactive oxygen species (ROS) had previously
been shown to be necessary for NLRP3 inflammasome activity [34],
inhibition of the mitochondrial voltage-dependent anion channel
(VDAC) abrogated both intracellular ROS levels and inflammasome
assembly, indicating that mitochondrial ROS production is directly
involved in NLRP3 inflammasome signaling of macrophages [35].
Subsequently, macrophages treated with E. coli lipopolysaccharide or
ATP (both inflammasome activators) displayed release of mtDNA into
the cytoplasm. Moreover, transfection to deliver cytoplasmic mtDNA
stimulated secretion of both IL-1β and IL-18, indicating that release
of mtDNA from the mitochondrial matrix into the surrounding
cytoplasm directly contributes to NLRP3 inflammasome activity.
Shimada et al. [36] then found that mitochondrial dysfunction
J Clin Immunol Immunother ISSN: 2378-8844, Open Access Journal
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correlates with NLRP3 inflammasome activity, with binding of
oxidized mtDNA a required step in NLRP3 inflammasome activation
and IL-1β [36]. These results provide an unusual mechanism of
inflammasome activation: while mtDNA damage is increasingly
appearing as a common form of mitochondrial damage in a variety
of cellular settings [37,38], it is unclear how a highly packaged,
compacted circle of DNA [39,40] is released from a double
membrane-bound organelle into the cytoplasm. Future research will
undoubtedly shed new light on how mtDNA escapes the organelle to
participate in inflammatory signaling.
Additional studies suggest that entire mitochondrial organelles
are active players in NLRP3 inflammasome activity. Cardiolipin, a
diphosphatidylglycerol lipid, is found nearly exclusively in the
mitochondrial inner membrane. However, upon both ROS-dependent
and –independent induction of the NLRP3 inflammasome,
cardiolipin translocates to the outer membrane of the
mitochondria, where it interacts with the leucine-rich repeat (LRR)
domain of NLRP3, concurrent with ASC and caspase-1 recruitment
to the inflammasome leading to IL-1β secretion [41]. Cardiolipin
translocation to the outer membrane appears to be mediated by
phospholipid scramblase-3, contributing to mitochondrial
autophagy in rat cortical neurons [42], suggesting that binding
of cardiolipin by cytoplasmic signaling molecules is a general
stress-response mechanism in cells, with profound disease
implications. As a large-scale cytoplasmic macromolecular scaffolding
assembly, the NLRP3 inflammasome requires the tubulin cytoskeleton
to transport mitochondria to inflammasome sites, where they bind to
ASC [33]. The mitochondrial anti-viral signaling (MAVS) factor is a
likely adaptor protein mediating NLRP3-mitochondrial interaction,
required for IL-1β maturation and secretion in THC-1 monocytes,
as well as macrophages [43,44]. MFN2 is required for NLRP3
inflammasome activation following infection with RNA virus:
Ichinohe et al. found that this association requires an intact ∆ψm for
MFN2-NLRP3 interaction [45]. These studies indicate that a diverse
set of mitochondrial factors mediate activation of the NLRP3
inflammasome (Figure 1). MFN2 and MAVS, as proteins located in
the outer mitochondrial membrane, are easier to envision as ‘docking
partners’ with the NLRP3 protein, while translocation of cardiolipin
to the mitochondrial outer membrane and the release of mtDNA from
the organelle into the cytoplasm represent highly dynamic events in
inflammasome activation. These studies clearly demonstrate that
much remains to be understood regarding the roles these factors play
in inflammatory response, and further indicate that additional
mitochondrial factors localized to any part of the organelle may
be similarly involved in dynamic recruitment to the NLRP3
inflammasome. Further, the studies above (except where indicated)
have characterized NLRP3 signaling interactions in macrophages, as
major mediators of innate immune response. It is highly likely that
NLRP3-mediated signaling will show a range of specific responses in
different cell types throughout the body.

Inflammatory Damage to Mitochondria
In addition to their emerging role as integral contributors to
inflammatory response in the innate immune system, mitochondria
are increasingly implicated as cellular targets of cytokine-mediated
inflammation in a host of tissues. While macrophages and similar
immune cells involve mitochondria in inflammatory signaling, many
of the same cytokines have been shown to damage mitochondria in
the pathogenesis of prevalent human diseases, particularly Type 2
diabetes mellitus.
Volume 1 • Issue 1 • 100004
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Mitochondria have long been implicated in the pathogenesis
of Type 2 diabetes mellitus and associated metabolic disorders.
Decreased mitochondrial function [46,47] and gene expression
[48,49] have been strongly correlated with Type 2 diabetes in diverse
tissues such as skeletal muscle and peripheral blood. As such, an
abundance of clinical and experimental data indicates that decreased
mitochondrial function and bioenergetics capacity plays a
contributing role in Type 2 diabetes. However, it has been unclear
what genetic or environmental factors this can be attributed to.
Inherited mutations of mtDNA cause insulin resistance and diabetes
mellitus in patients [50,51], indicating that mitochondrial
dysfunction can be a causative determinant of insulin resistance.
Despite this, inherited pathogenic mtDNA mutations do not occur
frequently enough (1 in 5,000-10,000 individuals [52,53] to explain
the rapidly-expanding prevalence of Type 2 diabetes worldwide.
However, the emergence of cytokine-mediated inflammation
as a causative mechanism of Type 2 diabetes suggests that
cytokine-mediated damage to mitochondria plays a major role in the
pathogenesis of diabetes and co-morbid conditions.
Cytokine-mediated inflammation has gained recognition as a
major causative force in the development of insulin resistance
and diabetes [54-56]. While the initial studies demonstrating this
causative mechanism explored the ability of TNF-α to mediate
insulin resistance [55], subsequent studies built upon these findings
to include IL-1β, IL-6, IL-18, resistin, leptin, adiponectin, and others.
Many of these are expressed both by macrophages and adipocytes,
providing a mechanistic link for the co-morbidity of Type 2 diabetes
and obesity [57]. Upon binding of these cytokines to PRRs at the
plasma membrane, the NFκB and JNK pathways are activated,
mediating crucial stress-mediated transcription of inflammatory
factors (such as IL-1β and NLRP3, above). The NLRP3 inflammasome
is activated in cytokine-mediated insulin resistance [58,59] and
mediates impaired wound healing through sustained inflammation in
diabetic patients [60].
Many of these same cytokines have been shown to directly
damage mitochondria. TNF-α cause rapid damage to mtDNA
and increased ROS production [61], and inhibits mitochondrial
bioenergetics [62]. This TNF-α-induced damage is dependent
on TNF-R1 binding, and appears to involve stress-response
translocation of p53 to mitochondria [61,63]. Similarly,
heat-inactivated E. coli activates TLR-4, causing mtDNA depletion
[64]. These findings are concordant with experimental and clinical
data showing loss of mtDNA content and bioenergetic function
[65-67]. This mitochondrial damage has wide-ranging effects on
the cell at large. Mitochondrial involvement in the development of
insulin resistance appears to occur via elevated mitochondrial ROS
production, rather than decreased OxPhos activity per se [68].
Mitochondrial dysfunction has been suggested to cause insulin
resistance by decreasing insulin receptor substrate-1 (IRS1)
expression [69,70]. Mechanistically, loss of mtDNA has been shown
to effect broad changes in nuclear transcription via ‘retrograde’
mitochondria-to-nucleus signaling, in which mitochondrial
dysfunction affects pathways including NFkB and JNK to add to
cellular stress response [71,72]. The specific impacts of mitochondrial
dysfunction on gene expression of various inflammatory factors
are likely to provide insight into a critical cell-wide consequence of
mitochondrial dysfunction.
While the connections between inflammatory signaling and
mitochondria have been best characterized in diabetes and metabolic
J Clin Immunol Immunother ISSN: 2378-8844, Open Access Journal
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disorders, these interactions are increasingly found across a range
of other prevalent diseases. Gene expression profiling [73,74] and
biomarker studies find increases in cytokines in autistic subjects
[75], particularly IL-6 and TNF-α [76-]. These studies are consistent
with findings of mitochondrial dysfunction and increased organellar
fission in brain samples of autistic individuals [79]. Similar
involvement of NLRP3-associated inflammation is found in
Alzheimer’s disease [80] and cardiomyopathy [81]. These associations
strongly suggest that inflammation and mitochondria comprise a
pathogenic axis that is likely to play a role in a wide range of
prominent human diseases.

Mitochondrial Factors as Inflammatory Messengers
As discussed above, the release of mtDNA from the organelle in
response to NLRP3-associated inflammatory stimuli is a highly novel,
dynamic response, suggesting that mtDNA is a key mediator of
intracellular inflammation. Recent evidence suggests that mtDNA
and associated factors may have further roles as extracellular
inflammatory mediators. Mathew et al. observed that extracellular,
partially degraded mtDNA causes induction of cytokine secretion,
most notably IL-1β, suggesting that mtDNA is itself a category of
damage-associated molecular pattern (DAMP) for recognition by
PRRs [82]. Similarly, Chaung et al. [83] found that transcription
factor A, mitochondrial (TFAM), the major mtDNA-packaging
protein, mediates inflammation in hemorrhagic shock [83]. These
findings strongly indicate that mtDNA and the other protein factors
directly associated with it [39] are released from mitochondria and
act as pro-inflammatory signaling factors, appearing as
clinically-relevant indicators of inflammation in experimental systems
and patients [84,85]. Just as the adaptive nature of the mitochondrial
network has become evident as a key element of cellular homeostasis,
these findings indicate the importance of mitochondrial factors as
mediators of inflammatory signaling. The mechanisms of
mitochondrial factor release will reveal exciting, highly novel
molecular dynamics of factors previously thought to reside exclusively
within mitochondria.

Conclusion
The specific interactions of mitochondrial factors with innate
inflammatory factors, particularly NLRP3, bring together two fields
of cell biology that previously had little apparent connection. These
interactions are of enormous importance medically, as increased
inflammation has emerged as a causative or contributory factor in a
wide range of many of the most rapidly-expanding diseases today. As
the dynamics and causes of both bioenergetic stress and inflammation
in human disease are uncovered, understanding the intrinsic
mechanistic connections of inflammatory signaling with
mitochondrial biology is increasingly vital to cellular homeostasis and
human health.
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